Live Breaking News & Updates on Tyne Medical

Stay updated with breaking news from Tyne medical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

-Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- ....

Simon Cooper , Chris Erdman , Praveen Tipirneni , Key Additions To Morphic Leadership Team , Development Program , Napp Pharmaceutical Research , Exchange Commission , University Of Newcastle Upon Tyne Medical School , Morphic Holding Inc , Wyeth Research , Human Genome Sciences , Kadmon Holdings , Securities Exchange , Chief Medical , Chief Medical Officer , Recent Corporate , Simple Endoscopic Activity Score , Morphic Leadership , Vice President , Global Project Head , Keros Therapeutics , Tyne Medical , First Quarter , Robarts Histopathology Index , Modified Mayo Clinic Score , Simple Endoscopic Score ,